Global experts, including several from Monash University, have developed guidelines to better manage multiple sclerosis (MS) in people over 50. Subscribe to our newsletter for the latest sci-tech news ...

Heidi Crayton, MD, and Maria Lopes, MD, discuss the impact of multiple sclerosis on patients, families, and caregivers, differentiate relapsing forms (relapsing-remitting and primary progressive) from ...

Researchers conducted a cohort study that suggests oral N-acetylglucosamine treatment can hinder neurodegeneration and inflammation associated with multiple sclerosis (MS). Oral treatment of ...

Multiple sclerosis (MS) affects close to 3 million people worldwide, and incidence rates have risen over the past decade. Currently, there is no established laboratory test to diagnose or monitor ...

Real-world use of an MS blood test shows how it helps monitor disease activity and guide treatment decisions in U.S. patients ...

Annalisa Morgan, MD, reflects on insights gained from the Consortium of Multiple Sclerosis Centers 2024 Annual Meeting regarding the management of multiple sclerosis (MS). She emphasizes the ...

MS symptoms can affect almost any part of the body and appear differently during a flare or remission. But, with the right treatment and management strategies, you can get relief. Multiple sclerosis ...

Optimal management of multiple sclerosis (MS), a chronic progressive disease of the central nervous system (CNS), is lacking. The disease has a complex and varied pathogenesis and is driven by immune ...